Louisiana State Employees Retirement System Exelixis, Inc. Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

A detailed history of Louisiana State Employees Retirement System transactions in Exelixis, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 79,100 shares of EXEL stock, worth $2.69 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

79,100

Previous 82,400 4.0%

Holding current value

$2.69 Million

Previous $1.85 Million 10.86%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$21.96 - $27.6 $72,468 - $91,080	-3,300 Reduced 4.0%	79,100 $2.05 Million
Q2 2024 Jul 24, 2024	SELL	$20.34 - $23.73 $99,666 - $116,277	-4,900 Reduced 5.61%	82,400 $1.85 Million
Q4 2023 Jan 29, 2024	SELL	$19.25 - $24.13 $55,825 - $69,977	-2,900 Reduced 3.22%	87,300 $2.09 Million
Q3 2023 Oct 17, 2023	SELL	$19.04 - $22.74 $93,296 - $111,425	-4,900 Reduced 5.15%	90,200 $1.97 Million
Q2 2023 Jul 18, 2023	BUY	$18.17 - $20.48 $165,347 - $186,368	9,100 Added 10.58%	95,100 $1.82 Million
Q1 2023 Apr 19, 2023	SELL	$16.3 - $19.41 $6,520 - $7,764	-400 Reduced 0.46%	86,000 $1.67 Million
Q4 2022 Jan 24, 2023	BUY	$14.96 - $17.39 $11,968 - $13,912	800 Added 0.93%	86,400 $1.39 Million
Q3 2022 Oct 19, 2022	BUY	$15.68 - $22.27 $21,952 - $31,178	1,400 Added 1.66%	85,600 $1.34 Million
Q2 2022 Jul 20, 2022	BUY	$17.44 - $23.16 $22,672 - $30,108	1,300 Added 1.57%	84,200 $1.84 Million
Q1 2022 Apr 22, 2022	BUY	$17.03 - $22.67 $25,545 - $34,005	1,500 Added 1.84%	82,900 $1.91 Million
Q4 2021 Jan 14, 2022	BUY	$15.84 - $21.88 $15,840 - $21,880	1,000 Added 1.24%	81,400 $1.49 Million
Q3 2021 Oct 12, 2021	SELL	$16.3 - $21.14 $14,670 - $19,026	-900 Reduced 1.11%	80,400 $1.7 Million
Q2 2021 Jul 16, 2021	BUY	$17.95 - $25.56 $3,590 - $5,112	200 Added 0.25%	81,300 $1.48 Million
Q1 2021 Apr 14, 2021	BUY	$20.53 - $25.22 $73,908 - $90,792	3,600 Added 4.65%	81,100 $1.83 Million
Q4 2020 Jan 11, 2021	BUY	$18.39 - $24.8 $5,517 - $7,440	300 Added 0.39%	77,500 $1.56 Million
Q3 2020 Oct 19, 2020	BUY	$20.67 - $26.94 $14,469 - $18,858	700 Added 0.92%	77,200 $1.89 Million
Q2 2020 Jul 13, 2020	BUY	$16.46 - $27.42 $49,380 - $82,260	3,000 Added 4.08%	76,500 $1.82 Million
Q4 2019 Jan 17, 2020	BUY	$15.15 - $18.89 $10,605 - $13,223	700 Added 0.96%	73,500 $1.3 Million
Q3 2019 Oct 24, 2019	SELL	$17.68 - $22.65 $76,024 - $97,395	-4,300 Reduced 5.58%	72,800 $1.29 Million
Q2 2019 Jul 15, 2019	SELL	$18.93 - $24.75 $62,469 - $81,675	-3,300 Reduced 4.1%	77,100 $1.62 Million
Q1 2019 Apr 15, 2019	BUY	$19.6 - $24.76 $21,560 - $27,236	1,100 Added 1.39%	80,400 $1.91 Million
Q4 2018 Jan 14, 2019	SELL	$13.65 - $21.8 $31,395 - $50,140	-2,300 Reduced 2.82%	79,300 $1.56 Million
Q3 2018 Oct 16, 2018	BUY	$15.87 - $22.4 $82,524 - $116,479	5,200 Added 6.81%	81,600 $1.45 Million
Q2 2018 Jul 18, 2018	BUY	$18.56 - $22.45 $1.42 Million - $1.72 Million	76,400 New	76,400 $1.64 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Exelixis, Inc. Transaction History